logo
  1. Home
  2. Stocks
  3. Lupin

Lupin Share Price

Large Cap | Pharmaceuticals and health care | NSE: LUPIN | BSE: 500257

₹1,971.05 image-124.65 (-5.95 %)

Last Updated: 04 Apr 2025 03:57 PM

Technicalsimage BULLISHimage

Overview

Open (₹) 2,089.95

High (₹) 2,089.95

Low (₹) 1,916.00

Prev. Close (₹) 2,095.70

Volume 30,86,630

VWAP (₹) 1,893.19

ROCE (%) 17.64

Industry P/E 46.49

TTM P/E 31.37

P/B Ratio 6.25

Market Cap (₹) Cr.89,991.25

Dividend Yield (%)0.41

EPS (₹) 41.87

ROE13.27%

Sales Growth (%) 20.25

Profit Growth (%)332.35

Day Range

2,089.952,089.95

L
H

52 Week Range

1,493.752,403.45

L
H

Historical Returns

Returns (6M)

-9.37 %

Returns (1Y)

24.18 %

Returns (3Y)

153.94 %

Returns (5Y)

181.56 %

Returns (6M)

-9.37 %

Returns (1Y)

24.18 %

Returns (3Y)

153.94 %

Returns (5Y)

181.56 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (344.95%) TTM EPS Growth
  • Company with Low Debt
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Company with 344.95% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years
  • Growth in Net Profit Margin (QoQ)
  • Growth in Annual Net Profit with increasing Profit Margin (YoY)
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BULLISH
Moving Averages
Technical Indicators
Bearish
Bullish

RSI 48.18

MFI 34.21

ATR 82.45

Commodity Channel Index -106.86

ROC125 -13.18

ROC21 -7.74

Williams %R -87.43

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current1,933.261,961.881,998.761,896.381,867.761,830.881,802.26
Week Ago1,961.562,017.782,047.611,931.731,875.511,845.681,789.46
Month Ago2,062.242,102.122,134.242,030.121,990.241,958.121,918.24

EMA & SMA
info_icon

1971.05

Current Price

EMA & SMApin

Bullish Moving Averages

7

Bearish Moving Averages

13

5 Day 1902.19

9 Day 1960.88

10 Day 1951.10

12 Day 1984.41

14 Day 2009.38

20 Day 2030.60

26 Day 2045.79

50 Day 2121.12

100 Day 2124.82

200 Day 2006.08

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell14 Nov, 2022₹747.002,28,477NSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy14 Nov, 2022₹747.002,28,477NSE
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell03 Nov, 2022₹707.452,28,477NSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy03 Nov, 2022₹707.452,28,477NSE
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell03 Oct, 2022₹679.852,45,648NSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy03 Oct, 2022₹679.852,45,648NSE
ISHARES INDIA INDEX MAURITIUS COMPANYblockSell08 Aug, 2022₹668.102,41,514NSE
ISHARES MSCI INDIA ETFblockBuy08 Aug, 2022₹668.102,41,514NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
09 Sept, 2021Dr. Kamal K SharmaDisposal₹985.0015,000NSE
06 Sept, 2021Neel Deshbandhu GuptaAcquisition₹2,650NSE
06 Sept, 2021Veda Nilesh GuptaAcquisition₹2,650NSE
06 Sept, 2021Nilesh D. GuptaDisposal₹5,300NSE
27 Aug, 2021Nilesh D. GuptaAcquisition₹943.585,300NSE
18 Aug, 2021Sunil MakhariaDisposal₹974.0020,000NSE
16 Aug, 2021Ramesh SwaminathanDisposal₹978.0010,000NSE
10 Jul, 2021Veda Nilesh GuptaAcquisition₹2,140NSE
10 Jul, 2021Nilesh D. GuptaDisposal₹2,140NSE
30 Jun, 2021Mr. Sunil MakhariaDisposal₹1,161.002,000NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
06 May, 2024Rs.8.0000 per share(400%)Final Dividend16 Jul, 202416 Jul, 2024
10 May, 2023Rs.4.0000 per share (200%)Final Dividend14 Jul, 202314 Jul, 2023
18 May, 2022Rs.4.0000 per share(200%)Final Dividend14 Jul, 202215 Jul, 2022

Announcements

DateSourceDetail
02 Apr, 2025BSE IndiaLupin Healthcare (UK) Limited, a wholly owned subsidiary of the Company, has acquired the entire share capital of Renascience Pharma Limited, United Kingdom.
02 Apr, 2025NSE IndiaLupin Limited has informed the Exchange regarding Acquisition
02 Apr, 2025NSE IndiaLupin Limited has informed the Exchange about Lupin Healthcare (UK) Limited, a wholly owned subsidiary of the Company having acquired the entire share capital of Renascience Pharma Limited, United Kingdom.
31 Mar, 2025NSE IndiaLupin Limited has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL
31 Mar, 2025NSE IndiaLupin Limited has informed the Exchange regarding Slump Sale
31 Mar, 2025BSE IndiaModification to the slump sale transaction of transfer of the Over-the-Counter Consumer Healthcare Business.
31 Mar, 2025NSE IndiaLupin Limited has informed the Exchange regarding modification to the slump sale transaction of transfer of the Over-the-Counter Consumer Healthcare Business.
31 Mar, 2025BSE IndiaTransfer of Company''s API R&D Division to Lupin Manufacturing Solutions Limited, wholly owned subsidiary of the Company on slump sale basis.
31 Mar, 2025NSE IndiaLupin Limited has informed the Exchange regarding transfer of Company s API R&D Division to Lupin Manufacturing Solutions Limited, wholly owned subsidiary of the Company on a slump sale basis.
31 Mar, 2025BSE IndiaOutcome of the Board Meeting held on March 31, 2025.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results & OthersTo consider other business matters.29 Jan, 202511 Feb, 2025
Quarterly Results--23 Oct, 202407 Nov, 2024
Quarterly Results--24 Jul, 202406 Aug, 2024
Audited Results & Final Dividend--23 Apr, 202406 May, 2024
Quarterly Results--24 Jan, 202407 Feb, 2024
Quarterly Results--26 Oct, 202308 Nov, 2023
Quarterly Results--24 Jul, 202303 Aug, 2023
Audited Results & Final Dividend--26 Apr, 202309 May, 2023
Quarterly Results--26 Jan, 202309 Feb, 2023
Quarterly Results--09 Nov, 202209 Nov, 2022

Share Holding Pattern

Loading...

Dec 2024Dec 2023Dec 2022Dec 2021Dec 20200255075100
  • Promoter
  • FII
  • DII
  • Public

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group46.95%47.04%47.1%46.81%46.88%
Foreign Institutions +22.04%16.11%13.98%15.28%18.97%
Domestic Institutions +24.73%29.72%29.39%24.83%21.07%
Government0.01%0.01%0%0%0%
Public6.27%7.12%9.53%13.08%13.08%
Others0%0%0%0%0%

About Lupin

Lupin is a Public Limited Listed company incorporated on 01/03/1983 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1983PLC029442 and registration number is 029442. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 14666.50 Cr. and Equity Capital is Rs. 91.14 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Lupin Group

Founded

1983

Managing Director

Mr. Nilesh D Gupta

NSE Symbol

LUPIN

Lupin Management

NameDesignation
Mrs. Manju D GuptaChairman
Mr. Nilesh D GuptaManaging Director
Ms. Vinita GuptaDirector & CEO
Mr. Ramesh SwaminathanExecutive Director & Global CFO
Mr. Mark D McDadeIndependent Director
Dr. Punita Kumar-SinhaIndependent Director
Mr. Jean-Luc BelingardIndependent Director
Mr. Jeffrey KindlerIndependent Director
Mr. Alfonso ZuluetaIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,24,682.29₹1,709.35 image
₹1,770.00(-3.43%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,52,989.54₹5,482.85 image
₹5,763.00(-4.86%)		₹3,556.300 - ₹6,448.750
Cipla₹1,20,795.29₹1,415.25 image
₹1,495.70(-5.38%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,09,916.93₹3,286.50 image
₹3,247.70(1.19%)		₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,00,161.69₹2,451.20 image
₹2,427.70(0.97%)		₹1,910.100 - ₹3,050.000

FAQs on Lupin

What is the share price of Lupin?

The share price of Lupin on 04 Apr, 2025 is ₹ 1,971.05.

What is 52W high and 52W low share price of Lupin?

The highest and lowest 52W share prices of Lupin are ₹ 2403.450 and ₹ 1493.750

What is the market cap of Lupin?

The market capitalization of Lupin as of 04 Apr, 2025 is ₹ 89,991.25 Crores

What is the P/E ratio of Lupin?

The current P/E ratio of Lupin as of 04 Apr, 2025 is 46.49

What is the PB ratio of Lupin?

The PB ratio of Lupin as of 04 Apr, 2025 is 6.25

Top Gainers

BALPHARMA

Bal Pharma

₹109.04image

₹90.87 (0.20%)

MARALOVER

Maral Overseas

₹75.34image

₹62.79 (0.20%)

CHEMCRUX

Chemcrux Enterprises

₹143.15image

₹119.30 (0.20%)

ORCHASP

Orchasp

₹3.81image

₹3.18 (0.20%)

Top Losers

GRWRHITECH

Garware Hi-Tech Films

₹3,206.90image

₹3,774.25 (-0.15%)

BILLWIN

Billwin Industries

₹28.50image

₹32.80 (-0.13%)

POKARNA

Pokarna

₹950.60image

₹1,188.25 (-0.20%)

AVANTIFEED

Avanti Feeds

₹753.20image

₹889.55 (-0.15%)

Market Indices

Sensex

₹76,295.36image

₹76,617.44 (0.00%)

Source : Dion Global Solutions Limited